We willhaveexclusivityInsidersinvested$26.5mAn actualiMSCupdateWe expect tofinish theMino-Loktrial this yearI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Anymentionof Mino-WrapOnly biotechwith 2 Myron'son theleadershipteamI'm ashareholdermyselfWe haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetI/ONTAK'spotentialmarket is>$300mHemorrhoidsis a $2BmarketMino-Lokpotentialmarket>$1BThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeWe will openupinternationalsites forMino-Lok trialOur Halo-Lido trial willhave finalpatient byend of 2022We willhaveexclusivityInsidersinvested$26.5mAn actualiMSCupdateWe expect tofinish theMino-Loktrial this yearI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Anymentionof Mino-WrapOnly biotechwith 2 Myron'son theleadershipteamI'm ashareholdermyselfWe haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022We had aphase 2btrial with100%efficacyNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetI/ONTAK'spotentialmarket is>$300mHemorrhoidsis a $2BmarketMino-Lokpotentialmarket>$1BThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeWe will openupinternationalsites forMino-Lok trialOur Halo-Lido trial willhave finalpatient byend of 2022

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We will have exclusivity
  2. Insiders invested $26.5m
  3. An actual iMSC update
  4. We expect to finish the Mino-Lok trial this year
  5. I won't dilute shareholders
  6. Myron Holubiak and I founded a private company in 2013
  7. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  8. Any mention of Mino-Wrap
  9. Only biotech with 2 Myron's on the leadership team
  10. I'm a shareholder myself
  11. We have enough cash to go well into 2023
  12. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  13. We intend to submit a BLA in 2H 2022
  14. We had a phase 2b trial with 100% efficacy
  15. Not many companies this size with 2 late stage assets
  16. I/ONTAK is our lead asset
  17. I/ONTAK's potential market is >$300m
  18. Hemorrhoids is a $2B market
  19. Mino-Lok potential market >$1B
  20. There are no FDA approved drugs to treat hemorrhoids
  21. Mino-Lok is our lead asset
  22. I/ONTAK was the best deal I ever made
  23. We will open up international sites for Mino-Lok trial
  24. Our Halo-Lido trial will have final patient by end of 2022